Belgium torn over trisomy 21 and cytomegalovirus testing in pregnancy
This article was originally published in Clinica
A controversy is brewing in Belgium over whether testing for trisomy 21 and cytomegalovirus should be undertaken routinely in pregnant women. Some 300 children are born handicapped as a result of trisomy 21 and cytomegalovirus every year in Belgium, and it is thought that the test would be able to detect the condition in over two thirds of cases. However, there is no uniform testing policy, although all pregnant women are tested for toxoplasmosis, HIV, hepatitis B and syphilis.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.